Compile Data Set for Download or QSAR
Report error Found 28 Enz. Inhib. hit(s) with all data for entry = 50047611
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50178705(CHEMBL3814804)
Affinity DataIC50: 1.5nMAssay Description:Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2017
Entry Details Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50398334(CHEMBL2178578)
Affinity DataIC50: 5nMAssay Description:Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2017
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50178714(CHEMBL3814136)
Affinity DataIC50: 8nMAssay Description:Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2017
Entry Details Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50178704(CHEMBL3814736)
Affinity DataIC50: 20nMAssay Description:Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2017
Entry Details Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50178716(CHEMBL3814511)
Affinity DataIC50: 29nMAssay Description:Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2017
Entry Details Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50178707(CHEMBL3814811)
Affinity DataIC50: 35nMAssay Description:Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2017
Entry Details Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50178712(CHEMBL3813888)
Affinity DataIC50: 36nMAssay Description:Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2017
Entry Details Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50178709(CHEMBL3814683)
Affinity DataIC50: 70nMAssay Description:Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2017
Entry Details Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50178713(CHEMBL3815051)
Affinity DataIC50: 75nMAssay Description:Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2017
Entry Details Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50178711(CHEMBL3814176)
Affinity DataIC50: 85nMAssay Description:Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2017
Entry Details Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50178717(CHEMBL3815007)
Affinity DataIC50: 93nMAssay Description:Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2017
Entry Details Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50178942(CHEMBL3814546)
Affinity DataIC50: 111nMAssay Description:Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2017
Entry Details Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50178708(CHEMBL3814251)
Affinity DataIC50: 113nMAssay Description:Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2017
Entry Details Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50178943(CHEMBL3814577)
Affinity DataIC50: 207nMAssay Description:Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2017
Entry Details Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50178707(CHEMBL3814811)
Affinity DataIC50: 218nMAssay Description:Inhibition of CCR9-mediated chemotaxis in human MOLT4 cells preincubated for 10 mins followed by TECK addition in presence of 0.1% BSA measured after...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2017
Entry Details Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50178703(CHEMBL3814202)
Affinity DataIC50: 232nMAssay Description:Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2017
Entry Details Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50178944(CHEMBL3814185)
Affinity DataIC50: 232nMAssay Description:Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2017
Entry Details Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50178704(CHEMBL3814736)
Affinity DataIC50: 277nMAssay Description:Inhibition of CCR9-mediated chemotaxis in human MOLT4 cells preincubated for 10 mins followed by TECK addition in presence of 0.1% BSA measured after...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2017
Entry Details Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50178706(CHEMBL3814037)
Affinity DataIC50: 378nMAssay Description:Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2017
Entry Details Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50178718(CHEMBL3814598)
Affinity DataIC50: 451nMAssay Description:Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2017
Entry Details Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50178708(CHEMBL3814251)
Affinity DataIC50: 590nMAssay Description:Inhibition of CCR9-mediated chemotaxis in human MOLT4 cells preincubated for 10 mins followed by TECK addition in presence of 0.1% BSA measured after...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2017
Entry Details Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50178709(CHEMBL3814683)
Affinity DataIC50: 1.05E+3nMAssay Description:Inhibition of CCR9-mediated chemotaxis in human MOLT4 cells preincubated for 10 mins followed by TECK addition in presence of 0.1% BSA measured after...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2017
Entry Details Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50178703(CHEMBL3814202)
Affinity DataIC50: 1.37E+3nMAssay Description:Inhibition of CCR9-mediated chemotaxis in human MOLT4 cells preincubated for 10 mins followed by TECK addition in presence of 0.1% BSA measured after...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2017
Entry Details Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50178706(CHEMBL3814037)
Affinity DataIC50: 2.60E+3nMAssay Description:Inhibition of CCR9-mediated chemotaxis in human MOLT4 cells preincubated for 10 mins followed by TECK addition in presence of 0.1% BSA measured after...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2017
Entry Details Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50178705(CHEMBL3814804)
Affinity DataIC50: 5.40E+3nMAssay Description:Inhibition of CCR9-mediated chemotaxis in human MOLT4 cells preincubated for 10 mins followed by TECK addition in presence of 0.1% BSA measured after...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2017
Entry Details Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50178715(CHEMBL3814368)
Affinity DataIC50: 8.40E+3nMAssay Description:Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2017
Entry Details Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50178710(CHEMBL3815082)
Affinity DataIC50: 1.00E+4nMAssay Description:Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2017
Entry Details Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50178719(CHEMBL3814735)
Affinity DataIC50: 5.00E+4nMAssay Description:Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2017
Entry Details Article
PubMed